Clinical trial
Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis: a Randomized, Double-blind, Placebo-controlled Clinical Study
NCT06674759 is registered in ClinicalTrials.gov with Guang'anmen Hospital of China Academy of Chinese Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Tongren-Dahuoluo Bolus in Patients with Knee Osteoarthritis: a Randomized, Double-blind, Placebo-controlled Clinical Study
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- January 10, 2025
- Completion date
- December 30, 2025
- Enrollment
- 72 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis (knee oa)